Haemonetics Signs Non-Exclusive Supply Agreement with CSL Plasma for NexSys PCS Devices

summarizeSummary

Haemonetics announced a non-exclusive supply agreement with CSL Plasma for its NexSys PCS devices and disposables, with CSL expected to transition some U.S. centers, though scope and timing are undetermined and guidance remains unchanged.

check_boxKey Events · M&A and Partnerships · HAE

• CSL Plasma Supply Agreement

  Haemonetics entered into a non-exclusive supply agreement with CSL Plasma for NexSys PCS devices with Persona PLUS technology and related disposables in the U.S.

• No Minimum Commitments

  The agreement does not include minimum purchase commitments, and CSL is expected to transition a portion of its U.S. plasma collection centers, though scope and timing are undetermined.

• Guidance Unchanged

  Haemonetics is not updating its fiscal 2027 guidance at this time, with an update expected on the Q2 FY27 earnings call in November 2026.

auto_awesomeAnalysis · HAE · Industrial Applications And Services

A new supply agreement with CSL Plasma, one of the largest plasma collection companies, positions Haemonetics to provide its NexSys PCS devices with Persona PLUS technology and related disposables. The deal is non-exclusive and carries no minimum purchase commitments, yet CSL is expected to transition a portion of its U.S. centers to Haemonetics' platform. Scope and timing remain undetermined, so fiscal 2027 guidance is unchanged for now, with an update anticipated on the Q2 earnings call in November 2026. This partnership could meaningfully expand Haemonetics' installed base and recurring disposables revenue, though the absence of commitments and exclusivity tempers the immediate impact.